Why I Bought Illumina
-
Font Size:
Wednesday on twitter, I "tweeted" that I was most likely going to get long Illumina (ILMN), and that's exactly what I did. If you haven't noticed, there's been a big rotation into healthcare/biotech/bioscience companies as of late. I already have exposure to this somewhat through Gilead (GILD), Biiogen (BIIB), and Thermo Fisher (TMO). But, the positions are smaller relative to my overall portfolio. So, I wanted to increase my exposure there while still maintaining diversification in the various health/bio sectors. In this market, you play what's working.
Taken from Google Finance:
Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. Using its technologies, the Company provides a line of products and services that serve the sequencing, genotyping and gene expression markets. The Company’s customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies. Its tools provide researchers with the capability to perform genetic tests needed to extract medical information from advances in genomics and proteomics.
Straight up, ILMN scares me - I'm not kidding. Its valuation is ridiculous and borderline insane. It has a trailing P/E of nearly 160 and a forward P/E of 41. However, this name continues to cruise higher and has had me interested for a while. We finally got a pullback to support and I pulled the trigger. I am keeping a very tight stop on this name for fear that it could have its head chopped off at any minute due to its sky high valuation.
click to enlarge
As you can see from the chart above, ILMN has pulled back from $90 to around $82 or so in an orderly fashion. That 82 level has served as a nice little area of support recently so I figured to start my buying here. The main level of support I'm concerned with though is below that at $80. As you can see, ILMN bumped up against 80 from April until early June as that area was extreme resistance. Now that ILMN has blown past that resistance, I am ultimately looking for the re-test of this area as it now should be support. At that level, I will add handsomely to my position.
The $80 level is also key simply because it is also right below the 50-day moving average and serves as my stop loss. If it cannot hold this big area of support, it is going lower and I want out fast. Again, the valuation scares me and it could come crashing down with no explanation. I want in this name for fundamental reasons (not valuation) because the company is really progressing and gaining a lot of attention/support.
However, in this increasingly volatile market, you really have to make sure you're focusing on risk management. Managing your risk/reward is half the game in this whacky market. The chart has presented me with a clear exit plan and I'm comfortable getting into this name because the price action is pretty crisp and I've got a clear game plan to manage my risk.
Therefore, I'm in with my initial position at $83.xx and a big order around $80 and a very tight stop below that at $79. This is not a trade - it is an investment. It simply looks like a trade due to the very tight stop I have on it due to lofty valuations and a volatile market. People who are just buying and holding in this market are most likely being slaughtered. You've got to adapt and maneuver around positions to ensure that at the very least you're preserving capital, if not
Disclosure: The author is long ILMN.
- SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial »
- Immtech Pharmaceuticals, Inc. F1Q09 (Qtr End 06/30/08) Earnings Call Transcript »
- Five Biopharma Companies Drop on Negative Drug News »
- Amylin, Lilly: Another Case of a Panic Driven Sell-Off »
- Drug Safety Updates For Elan, Biogen, Amylin, and Lilly »
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
ETFs In Focus
-
Editor's Picks
-
Most Popular
- Latest Commodities Indicator: Fed Policy
- Thoughts on Mohamed El-Erian's 'When Markets Collide'
- Priceline: More Headwinds Ahead
- PFI: PowerShares Dynamic Financials Outperforms Its Peers
- Interview with Kevin Carter, AlphaShares CEO
- Report from the Bond War Frontlines
- Full list of Editor's Picks »
- Has Jim Cramer Crossed the Line with Sirius XM? »
- Buffett Takes Berkshire Hathaway on $4 Billion Spending Spree »
- Wall Street Breakfast: Must-Know News »
- Wall Street Breakfast: Must-Know News »
- Wall Street Breakfast: Must-Know News »
- Sirius XM Belt Tightening Begins »
- Sirius XM Shorts Scrambling to Cover »
- No Leadership from Apple Right Now »
- Leave Sirius Alone! »
- AIG and the Lunacy of GAAP Reporting »
- Solarfun Power Holdings Co., Ltd. Q2 2008 Earnings Call Transcript »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Faith Doesn't Cut It - Cramer's Mad Money (8/29/08)
- Again With the Financials - Fast Money Recap (8/29/08)
- Potash One Will Be Top Performer in Agriculture Bull Market
- Luxury Retail Stocks: Two Worth a Look
- 11 Top Canadian Dividend Stocks Available as ADRs
- Natural Gas Is Oversold, and We Are Buying
- Libbey Inc.: The Glass is Half Full
- Mad Money Manual - Cramer's Mad Money (8/28/08)
- An Eye on Gustav - Fast Money Recap (8/28/08)
- Will You Look Back on Today as Your Greatest Missed Opportunity?
- Full list of Long Ideas »
- Priceline: More Headwinds Ahead
- The Option Arm Triplets: Dead Banks Walking
- Short Thesis Still Intact at FirstFed
- Short Story: Lehman
- 'Buy, But Sell' - What Are Analysts Thinking?
- Nordson's Rally Is Over, For Now - Barron's
- What's So Special About RadioShack? - Barron's
- Salesforce.com: It's All About the Guidance
- Three Casino Stocks Rolling Over
- New Web Site For Short Sellers: You Gotta Love Capitalism
- Full list of Short Ideas »
- Faith Doesn't Cut It - Cramer's Mad Money (8/29/08)
- Mad Money Manual - Cramer's Mad Money (8/28/08)
- Diversified Portfolios - Cramer's Mad Money (8/27/08)
- Gustav Moves Overdone - Cramer's Stop Trading! (8/27/08)
- GrafTech is Too Cheap - Cramer's Stop Trading
- The Rebound List - Cramer's Mad Money (8/26/08)
- The List - Cramer's Stop Trading! (8/26/08)
- Can't Turn My Back - Cramer's Lightning Round (8/26/08)
- The Pelosi Factor - Cramer's Mad Money (8/25/08)
- Buy Tech Weakness - Cramer's Lightning Round (8/25/08)
- Full list of Cramers Picks »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »


